Work

Abstract 4340: DM1 pharmacokinetics in combination with tucatinib in patients with HER2+ LA/M breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4340

Authors: Ariel R. Topletz-Erickson, Diqiong Xie, Flavia Storelli, Julie Meyer, Shawna Hengel, Wentao Feng, Lauren Farr, Amit Garg

Institution: Pfizer (United States)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409625665

Cites:

Cited by:

Related to: 10